Print Page  Close Window


SEC Filings

8-K
OREXIGEN THERAPEUTICS, INC. filed this Form 8-K on 12/14/2018
Entire Document
 


In re: Orexigen Therapeutics, Inc.

Debtor

  

Case No. 18-10518 (KG)

Reporting Period: November 1, 2018 - November 30, 2018

 

MOR - 1a

Schedule of Disbursements by Debtor Entity (1)

For the Period: November 1, 2018 - November 30, 2018

(Unaudited)

 

$ USD ‘000s

Debtor         

   November 1, 2018 - November 30, 2018      Cumulative
Since Filing
 

Orexigen Therapeutics, Inc.

   $ 1,136      $ 136,332  
  

 

 

    

 

 

 

Total

   $ 1,136      $ 136,332  

Notes:

 

(1)

The Schedule of Disbursements is presented on a book basis.